FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2960 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE, and the VA provide coverage for in vitro fertilization (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertilization (IVF) for military service-connected injuries. H.R. 2087 - the "Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Foreign entity interest: Ferring International Center S.A. (Ferring Global) supports the policy issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LILLIAN VERNE GERMAN | Counsel, House Judiciary Committee; Chief of Staff (Reps. Hastings, E.B. Johnson, B. Lee, Jackson-Lee) |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.